Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Rocagloic acid, a rocaglamide derivative sourced from Aglaia elliptifolia fruit, exhibits significant cytotoxicity [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | Rocagloic acid, a rocaglamide derivative sourced from Aglaia elliptifolia fruit, exhibits significant cytotoxicity [1]. |
In vitro | Rocaglamide exhibits selective cytotoxicity toward the NCI-H187 cell line, evidenced by an ED50 value of 0.036 ng/mL, while demonstrating inactivity against both human epidermoid carcinoma (KB) and human breast cancer (BC) cells [1]. |
Molecular Weight | 478.49 |
Formula | C27H26O8 |
CAS No. | 190385-15-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Rocagloic acid 190385-15-0 inhibitor inhibit